TRPV1/VR1 Blocking Peptide (#BLP-CC030) is the original antigen used for immunization during Anti-TRPV1 (VR1) Antibody (#ACC-030) generation. The blocking peptide binds and ‘blocks’ Anti-TRPV1/VR1 primary antibody, this makes it a good negative reagent control to help confirm antibody specificity in western blot and immunohistochemistry applications. This control is also often called a pre-adsorption control.
- Western blot analysis of human TRPV1 transfected HEK-293 cells:
- Western blot analysis of rat DRG lysate:
- Expression of TRPV1 in rat DRGImmunohistochemical staining of rat dorsal root ganglion (DRG) using Anti-TRPV1 (VR1) Antibody (#ACC-030). A. TRPV1 (red) in DRG neurons. B. Staining with mouse anti-Parvalbumin (green) in the same DRG section. C. Confocal merge of TRPV1 and Parvalbumin demonstrates colocalization (arrows).
- Western blot analysis of Rat DRG lysate:1. Guinea pig Anti-TRPV1 (VR1) Antibody (#ACC-030-GP), (1:200).
2. Guinea pig Anti-TRPV1 (VR1) Antibody preincubated with TRPV1/VR1 Blocking Peptide (#BLP-CC030).
Following a broad screen of secondary antibodies, the following were used for these applications: Western blot analysis: #106-035-006 (Jackson ImmunoResearch).
- Expression of TRPV1 in rat DRGsImmunohistochemical staining of TRPV1 in rat dorsal root ganglion (DRG) using Guinea pig Anti-TRPV1 (VR1) Antibody (#ACC-030-GP), (1:200). A. TRPV1 staining (red) appears in some DRG cells (arrows). B. DAPI counterstain (blue) is used to stain nuclei. C. Merged image of panels A and B.
- (C)EDAEVFKDSMVPGEK, corresponding to amino acid residues 824-838 of rat TRPV1 (Accession O35433).